Top Pharmaceuticals companies in United States by EBIT Margin

This ranking features the top 621 Pharmaceuticals companies in United States ranked by EBIT Margin, averaging a EBIT Margin of -3,242,713.77%, for January 15, 2025.

United States

Pharmaceuticals

#	Name	EBIT Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	95,369.20%	Sept. 30, 2024	USD 12.74	-6.60%	United States
2	Oramed Pharmaceuticals Inc. 2 ORMP	1,540.65%	March 31, 2024	USD 2.36	NA	United States
3	Maravai LifeSciences Holdings, Inc. 3 MRVI	178.05%	Sept. 30, 2024	USD 4.54	-7.91%	United States
4	SIGA Technologies, Inc. 4 SIGA	60.19%	Sept. 30, 2024	USD 6.33	4.46%	United States
5	United Therapeutics Corporation 5 UTHR	52.28%	Sept. 30, 2024	USD 364.70	0.50%	United States
6	Halozyme Therapeutics, Inc. 6 HALO	51.60%	Sept. 30, 2024	USD 53.83	-0.57%	United States
7	SWK Holdings Corporation 7 SWKH	49.75%	Sept. 30, 2024	USD 16.15	-0.92%	United States
8	Protagonist Therapeutics, Inc. 8 PTGX	45.78%	Sept. 30, 2024	USD 36.67	-1.26%	United States
9	Lantheus Holdings, Inc. 9 LNTH	39.41%	Sept. 30, 2024	USD 92.62	-2.15%	United States
10	MEI Pharma, Inc. 10 MEIP	38.46%	June 30, 2024	USD 2.75	1.10%	United States
11	Zoetis Inc. 11 ZTS	36.61%	Sept. 30, 2024	USD 164.41	-1.15%	United States
12	Catalyst Pharmaceuticals, Inc. 12 CPRX	35.70%	Sept. 30, 2024	USD 22.19	-0.09%	United States
13	Utah Medical Products, Inc. 13 UTMD	33.70%	Sept. 30, 2024	USD 61.49	0.77%	United States
14	Semler Scientific, Inc. 14 SMLR	33.43%	Sept. 30, 2024	USD 54.93	4.23%	United States
15	Collegium Pharmaceutical, Inc. 15 COLL	33.14%	Sept. 30, 2024	USD 33.18	-1.80%	United States
16	Royalty Pharma plc 16 RPRX	31.67%	Sept. 30, 2024	USD 30.03	0.13%	United States
17	United-Guardian, Inc. 17 UG	31.53%	Sept. 30, 2024	USD 10.50	-0.19%	United States
18	Regeneron Pharmaceuticals, Inc. 18 REGN	31.50%	Sept. 30, 2024	USD 690.87	-3.63%	United States
19	IRadimed Corporation 19 IRMD	31.05%	Sept. 30, 2024	USD 57.52	1.79%	United States
20	ResMed Inc. 20 RMD	30.58%	Sept. 30, 2024	USD 228.83	-0.62%	United States
21	IDEXX Laboratories, Inc. 21 IDXX	29.34%	Sept. 30, 2024	USD 418.63	-0.94%	United States
22	Amphastar Pharmaceuticals, Inc. 22 AMPH	29.34%	Sept. 30, 2024	USD 38.48	1.48%	United States
23	Waters Corporation 23 WAT	29.30%	Sept. 28, 2024	USD 404.93	1.26%	United States
24	Sensus Healthcare, Inc. 24 SRTS	29.27%	Sept. 30, 2024	USD 6.64	4.08%	United States
25	Exelixis, Inc. 25 EXEL	29.22%	Sept. 27, 2024	USD 35.65	0.99%	United States
26	Prestige Consumer Healthcare Inc. 26 PBH	29.20%	Sept. 30, 2024	USD 75.78	1.54%	United States
27	AbbVie Inc. 27 ABBV	28.60%	Sept. 30, 2024	USD 175.55	-0.67%	United States
28	Ironwood Pharmaceuticals, Inc. 28 IRWD	27.51%	Sept. 30, 2024	USD 3.65	-3.18%	United States
29	Olaplex Holdings, Inc. 29 OLPX	26.71%	Sept. 30, 2024	USD 1.54	1.99%	United States
30	Eli Lilly and Company 30 LLY	26.54%	Sept. 30, 2024	USD 744.91	-6.59%	United States
31	Edwards Lifesciences Corporation 31 EW	26.45%	Sept. 30, 2024	USD 71.04	-0.07%	United States
32	Entrada Therapeutics, Inc. 32 TRDA	26.43%	Sept. 30, 2024	USD 12.49	-6.58%	United States
33	Harmony Biosciences Holdings, Inc. 33 HRMY	26.41%	Sept. 30, 2024	USD 36.42	-0.08%	United States
34	Neurocrine Biosciences, Inc. 34 NBIX	26.23%	Sept. 30, 2024	USD 139.51	-2.46%	United States
35	Intuitive Surgical, Inc. 35 ISRG	26.11%	Sept. 30, 2024	USD 538.88	-0.16%	United States
36	Johnson & Johnson 36 JNJ	25.34%	Sept. 29, 2024	USD 144.75	0.19%	United States
37	Danaher Corporation 37 DHR	24.50%	Sept. 27, 2024	USD 237.62	-0.94%	United States
38	Hologic, Inc. 38 HOLX	24.50%	Sept. 28, 2024	USD 70.20	-0.13%	United States
39	Biogen Inc. 39 BIIB	24.09%	Sept. 30, 2024	USD 143.06	-4.74%	United States
40	LeMaitre Vascular, Inc. 40 LMAT	23.81%	Sept. 30, 2024	USD 95.85	1.78%	United States
41	Krystal Biotech, Inc. 41 KRYS	23.75%	Sept. 30, 2024	USD 142.64	-5.10%	United States
42	Agilent Technologies, Inc. 42 A	23.73%	Oct. 31, 2024	USD 143.43	1.04%	United States
43	Merck & Co., Inc. 43 MRK	23.68%	Sept. 30, 2024	USD 99.65	-1.32%	United States
44	ADMA Biologics, Inc. 44 ADMA	23.58%	Sept. 30, 2024	USD 16.32	-1.03%	United States
45	Colgate-Palmolive Company 45 CL	23.14%	Sept. 30, 2024	USD 87.67	0.65%	United States
46	Amgen Inc. 46 AMGN	23.05%	Sept. 30, 2024	USD 267.10	-1.14%	United States
47	Corcept Therapeutics Incorporated 47 CORT	22.69%	Sept. 30, 2024	USD 51.66	1.18%	United States
48	Organon & Co. 48 OGN	22.27%	Sept. 30, 2024	USD 15.81	0.96%	United States
49	West Pharmaceutical Services, Inc. 49 WST	20.63%	Sept. 30, 2024	USD 328.96	-3.13%	United States
50	Zimmer Biomet Holdings, Inc. 50 ZBH	20.22%	Sept. 30, 2024	USD 104.71	-0.74%	United States

1 2 3 4 … 13

Frequently Asked Questions

Which Pharmaceuticals company in United States has the highest EBIT Margin ?

The Pharmaceuticals company in United States with the highest EBIT Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 95,369.20%.
Which Pharmaceuticals company in United States has the lowest EBIT Margin ?

The Pharmaceuticals company in United States with the lowest EBIT Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -2,006,393,700.00%.

What are the top 10 Pharmaceuticals companies in United States by EBIT Margin ?

The top 10 Pharmaceuticals companies in United States by EBIT Margin are Inhibrx Biosciences, Inc., Oramed Pharmaceuticals Inc., Maravai LifeSciences Holdings, Inc., SIGA Technologies, Inc., United Therapeutics Corporation, Halozyme Therapeutics, Inc., SWK Holdings Corporation, Protagonist Therapeutics, Inc., Lantheus Holdings, Inc. and MEI Pharma, Inc..
What are the bottom 10 Pharmaceuticals companies in United States by EBIT Margin ?

The bottom 10 Pharmaceuticals companies in United States by EBIT Margin are Inhibikase Therapeutics, Inc., Allogene Therapeutics, Inc., Forte Biosciences, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Benitec Biopharma Inc., Cadrenal Therapeutics, Inc. Common Stock, Summit Therapeutics Inc., NRx Pharmaceuticals, Inc. and Altimmune, Inc..